Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![MERCK Kommanditgesellschaft auf Aktien Graphic](https://lunarcrush.com/gi/w:26/t:$mrkde.png) MERCK Kommanditgesellschaft auf Aktien

MERCK stock sees mixed signals as positive analyst recommendations and a potential drug price deal offer support, but negative trial results for Xevinapant weigh on gains.

### About MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien (MRKDE) is a pharmaceutical and chemical company.  

### Insights [#](/topic/$mrkde/insights)
- MERCK Kommanditgesellschaft auf Aktien engagements is up XXXXXXXX% from the previous week.

### Price: $ [#](/topic/$mrkde/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mrkde/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/close.tsv)  
The price action is likely influenced by positive news regarding the White House's drug-buying site and analyst recommendations, potentially leading to an increase in stock value. However, the negative trial results for Xevinapant could temper the gains.  

**1-Year High**: $XXX on 2024-10-23  
**1-Year Low**: $XXXXXX on 2025-08-07  
  
  
### AltRank: undefined [#](/topic/$mrkde/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mrkde/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/alt_rank.tsv)  
MERCK Kommanditgesellschaft auf Aktien is currently AltRank #undefined based on combined combined social and market metrics
**Daily Average**: XXX  
**1-Year High**: XXX on 2025-04-01  
**1-Year Low**: XXX on 2025-03-07  
  
  
### Galaxy Score: XX [#](/topic/$mrkde/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mrkde/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1-Year High**: XX on 2025-03-03  
**1-Year Low**: XX on 2025-03-23  
  
  
### Engagements: XX [#](/topic/$mrkde/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mrkde/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XXX +3,513%  
**1 Month**: XXX +48%  
**6 Months**: XXXXXX -XX%  
**1 Year**: XXXXXXX +1,402%  
**1-Year High**: XXXXXX on 2025-03-06  
**1-Year Low**: X on 2024-11-03  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$mrkde/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mrkde/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: X +300%  
**6 Months**: XX -XX%  
**1 Year**: XX +347%  
**1-Year High**: XX on 2025-03-05  
**1-Year Low**: X on 2024-10-29  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$mrkde/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mrkde/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning MERCK Kommanditgesellschaft auf Aktien in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: X  
**1 Month**: X +300%  
**6 Months**: XX -XX%  
**1 Year**: XX +283%  
**1-Year High**: XX on 2025-03-05  
**1-Year Low**: X on 2024-10-29  
  
  
### Market Cap: $undefined [#](/topic/$mrkde/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mrkde/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mrkde/time-series/market_cap.tsv)  
**Current Value**: $undefined  
**Daily Average**: $XXXXXXXXXXXXXX  
**1-Year High**: $XXXXXXXXXXXXXX on 2024-10-23  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-03-27  

**Top assets mentioned**
In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours

[Merck & Co., Inc. (MRK)](/topic/$mrk)
[GSK plc (GSK)](/topic/$gsk)
[Novartis AG (NVS)](/topic/$nvs)
[Synthetify (SNY)](/topic/$sny)
[GSK plc (GSK)](/topic/gsk-plc)
[Sanofi (SNY)](/topic/sanofi)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[AstraZeneca PLC (AZN)](/topic/$azn)

**Top topics mentioned**
In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [investment](/topic/investment), [$mrk](/topic/$mrk), [manat](/topic/manat), [$gsk](/topic/$gsk), [$nvs](/topic/$nvs), [donald trump](/topic/donald-trump), [$sny](/topic/$sny), [$rhhby](/topic/$rhhby), [gsk plc](/topic/gsk-plc), [sanofi](/topic/sanofi), [tariffs](/topic/tariffs), [$pfe](/topic/$pfe), [$azn](/topic/$azn)

### Top Social Posts [#](/topic/$mrkde/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Merck KGaA stating a drug has near half-blockbuster potential One of the funnier things Ive seen in an investor presentation $MRK.DE"  
[X Link](https://x.com/occams_tooth/status/1978949899279302929) [@occams_tooth](/creator/x/occams_tooth) 2025-10-16T22:23Z XXX followers, XXX engagements


"Pharma pops off Premarket: $AZN +7% $RHHBY +6.7% $SNY +4.8% after $PFE clinches US drug price deal winning a 3Y tariff grace period under Trump plan. Street sees blueprint for peers $NVS $MRK.DE $GSK in talks with US to avoid XXX% drug import tariffs"  
[X Link](https://x.com/schaeffers/status/1973377220258238741) [@schaeffers](/creator/x/schaeffers) 2025-10-01T13:19Z 11.6K followers, XXX engagements


"Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA"  
[X Link](https://x.com/med__twi/status/1966952678518673568) [@med__twi](/creator/x/med__twi) 2025-09-13T19:50Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MERCK Kommanditgesellschaft auf Aktien Graphic MERCK Kommanditgesellschaft auf Aktien

MERCK stock sees mixed signals as positive analyst recommendations and a potential drug price deal offer support, but negative trial results for Xevinapant weigh on gains.

About MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien (MRKDE) is a pharmaceutical and chemical company.

Insights #

  • MERCK Kommanditgesellschaft auf Aktien engagements is up XXXXXXXX% from the previous week.

Price: $ #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by positive news regarding the White House's drug-buying site and analyst recommendations, potentially leading to an increase in stock value. However, the negative trial results for Xevinapant could temper the gains.

1-Year High: $XXX on 2024-10-23
1-Year Low: $XXXXXX on 2025-08-07

AltRank: undefined #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
MERCK Kommanditgesellschaft auf Aktien is currently AltRank #undefined based on combined combined social and market metrics Daily Average: XXX
1-Year High: XXX on 2025-04-01
1-Year Low: XXX on 2025-03-07

Galaxy Score: XX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-03-23

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +3,513%
1 Month: XXX +48%
6 Months: XXXXXX -XX%
1 Year: XXXXXXX +1,402%
1-Year High: XXXXXX on 2025-03-06
1-Year Low: X on 2024-11-03

Social Network X
Engagements XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X +300%
6 Months: XX -XX%
1 Year: XX +347%
1-Year High: XX on 2025-03-05
1-Year Low: X on 2024-10-29

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning MERCK Kommanditgesellschaft auf Aktien in the last XX hours which is up XX% from X in the previous XX hours Daily Average: X
1 Month: X +300%
6 Months: XX -XX%
1 Year: XX +283%
1-Year High: XX on 2025-03-05
1-Year Low: X on 2024-10-29

Market Cap: $undefined #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXX on 2024-10-23
1-Year Low: $XXXXXXXXXXXXXX on 2025-03-27

Top assets mentioned In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours

Merck & Co., Inc. (MRK) GSK plc (GSK) Novartis AG (NVS) Synthetify (SNY) GSK plc (GSK) Sanofi (SNY) Pfizer, Inc. (PFE) AstraZeneca PLC (AZN)

Top topics mentioned In the posts about MERCK Kommanditgesellschaft auf Aktien in the last XX hours

stocks healthcare, investment, $mrk, manat, $gsk, $nvs, donald trump, $sny, $rhhby, gsk plc, sanofi, tariffs, $pfe, $azn

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Merck KGaA stating a drug has near half-blockbuster potential One of the funnier things Ive seen in an investor presentation $MRK.DE"
X Link @occams_tooth 2025-10-16T22:23Z XXX followers, XXX engagements

"Pharma pops off Premarket: $AZN +7% $RHHBY +6.7% $SNY +4.8% after $PFE clinches US drug price deal winning a 3Y tariff grace period under Trump plan. Street sees blueprint for peers $NVS $MRK.DE $GSK in talks with US to avoid XXX% drug import tariffs"
X Link @schaeffers 2025-10-01T13:19Z 11.6K followers, XXX engagements

"Xevinapant with worse () EFS and PFS vs. placebo in phase X trial readout. Inhibitors of apoptosis protein inhibitors obviously not working as intended. Also confirms how hard it is to develop new chemo/RT combinations. $MRK.DE #MerckKGaA"
X Link @med__twi 2025-09-13T19:50Z XXX followers, XXX engagements

MERCK Kommanditgesellschaft auf Aktien
/topic/$mrkde